Importantly, SNORD63 in US and SNORD96A in plasma possessed the favorable diagnostic efficiency, suggesting that aberrant expression of SNORD63 and SNORD96A act as a diagnostic promising biomarker for ccRCC. The gene discussed is SNORD63; the disease is nonpapillary renal cell carcinoma.